Valentina E. Perotti
Via Venezian 1
Milan, 20133, Italy
Milan, 20133, Italy
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Landscape of immune-related signatures induced by targeting of different epigenetic regulators in melanoma: implications for immunotherapy.
Journal: Journal of experimental & clinical cancer research : CR
Published: August 02, 2022
An actionable axis linking NFATc2 to EZH2 controls the EMT-like program of melanoma cells.
Journal: Oncogene
Published: July 11, 2018
18F-Fluorocholine PET/CT Finding of a Vertebral Hemangioma.
Journal: Clinical nuclear medicine
Published: April 29, 2016
Sema6A and Mical1 control cell growth and survival of BRAFV600E human melanoma cells.
Journal: Oncotarget
Published: August 28, 2014
Towards combinatorial targeted therapy in melanoma: from pre-clinical evidence to clinical application (review).
Journal: International journal of oncology
Published: March 06, 2014
NFATc2 is a potential therapeutic target in human melanoma.
Journal: The Journal of investigative dermatology
Published: June 22, 2012
Role of Apollon in human melanoma resistance to antitumor agents that activate the intrinsic or the extrinsic apoptosis pathways.
Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: May 04, 2012
Showing 1-8 of 8
Last Updated: 09/26/2026